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Abstract

Author Manuscript

The developmental trajectories of emotional disorder symptoms during adolescence remain
elusive, owing in part to a shortage of intensive longitudinal data. In the present study, we charted
the temporal course of the tripartite model of anxiety and depression—which posits an
overarching negative affect dimension and specific anhedonia and anxious arousal dimensions—
over adolescence and emerging adulthood in order to construct a developmental map of the core
dimensions of emotional disorders. We recruited 604 high school juniors, overselecting those at
high risk for emotional disorders, and assessed the tripartite symptom domains five times annually.
Latent curve modeling revealed that negative affect and anxious arousal declined over follow up,
whereas anhedonia did not. Moreover, the correlation in rate of change varied across pairs of
symptom domains. Change in negative affect was moderately correlated with change in anxious
arousal, but change in anhedonia was not significantly related to change in any other domain.
Symptom trajectories, and the pattern of covariation among trajectories, were equivalent across
gender and comorbidity status. We discuss implications of these findings for developmental
models of anxiety and depression as well as transdiagnostic frameworks for emotional disorders.

General Scientific Summary

Author Manuscript

We charted a map of how anxiety and depression grow through adolescence, a period of peak risk
for emotional disorders. We found that the core elements of anxiety and depression do not develop
at the same rate or even in the same direction, on average. There may thus be multiple pathways to
emotional disorder during adolescence.
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Core Dimensions of Anxiety and Depression Change Independently During
Adolescence
The trajectories of emotional disorder symptoms are perhaps most unstable in adolescence.
Anxiety and depressive symptom levels can change dramatically during this period, as some
conditions (e.g., unipolar depression) tend to emerge for the first time and others (e.g.,
phobias) become entrenched (e.g., Hankin & Abramson, 2001; Lewinsohn, Clarke, Seeley,
& Rohde, 1994; Kessler et al. 2005). Developmental trends in these symptom domains defy
simple explanations. Not all emotional disorder symptoms change at the same speed, or even
in the same direction, during adolescence, despite high rates of diagnostic comorbidity (e.g.,
McLaughlin & King, 2015). Moreover, there is wide variation around average trends,
reflecting a diversity of possible trajectories.

Author Manuscript
Author Manuscript

Mapping the arcs of anxiety and depression over adolescence clearly requires intensive
longitudinal data. There are surprisingly few prospective studies with a follow up structure
suited to examine the rate and shape of symptom change. The available research generally
suggests that depressive symptoms increase steadily through adolescence and reach a
plateau at the transition to adulthood (Galambos, Barker, & Krahn, 2006; Galambos,
Leadbeater, & Barker, 2004; Ge, Lorenz, Conger, Elder, & Simons, 1994; Kim, Capaldi, &
Stoolmiller, 2003). However, several studies report zero growth, or even depression
symptom improvement, from mid- to late-adolescence (e.g., Galambos, Barker, & Krahn,
2006; Measelle, Stice, & Hogansen, 2006). Anxiety disorder symptoms appear to decline
gradually over the second decade of life (McGlaughlin & King, 2015; van Oort, GreavesLord, Verhulst, Ormel, & Huizink, 2009), although contradictory results have been reported
(Leadbeater, Thompson, & Gruppuso, 2012; Olino, Stepp, Keenan, Loeber, & Hipwell,
2014), and trajectories likely vary across the different anxiety disorders (Hale, Raaijmakers,
Muris, van Hoof, & Meeus, 2008; van Oort et al., 2009).

Author Manuscript

A focus on the core dimensions underlying anxiety and depression may provide a more
coherent picture of emotional disorder symptom change in adolescence. Negative affect is a
symptom dimension common to the full spectrum of anxiety and depressive disorders, and
its growth could be responsible for disorders changing together. Structural modeling of the
emotional disorder domain shows that disorders also are characterized by more specific (i.e.,
unique) psychopathological dimensions, and these could account for divergent symptom
trajectories (e.g., Krueger, 1999; Markon, 2010; Prenoveau et al., 2010). Traditional
assessments of emotional disorders do not adequately distinguish the common versus
specific components of anxiety and depression (Clark & Watson, 1991). Therefore, prior
longitudinal studies may have overestimated the similarity of emotional disorder trajectories
by emphasizing shared symptom dimensions of anxiety and depression (e.g., negative
affect).
The tripartite model—along with closely related formulations, such as the integrative
hierarchical model (Mineka, Watson, & Clark, 1998) and the trilevel model (NaragonGainey, Prenoveau, Brown & Zinbarg, in press; Prenoveau et al., 2010)—of anxiety and
depression aims to separate the common and specific symptom dimensions of emotional
disorders (Clark & Watson, 1991). This model stipulates that (i) negative affect is common
J Abnorm Psychol. Author manuscript; available in PMC 2018 February 01.

Conway et al.

Page 3

Author Manuscript

to all emotional disorders and is a major reason for their comorbidity, (ii) anhedonia (i.e.,
low positive affect) is more narrowly associated with depression and social anxiety, and (iii)
anxious arousal is specifically associated with anxiety (especially panic disorder).
A wealth of cross-sectional research has validated the tripartite configuration in diverse
community and clinical samples (e.g., Kotov, Gamez, Schmidt, & Watson, 2010; Watson,
Gamez, & Simms, 2005). The dimensions are distinct yet moderately correlated (NaragonGainey, Watson, & Markon, 2009; Watson & Naragon-Gainey, 2014; Watson et al., 1995;
Zinbarg & Barlow, 1996), explain complex emotional disorder comorbidity patterns (Brown,
Chorpita, & Barlow, 1998), and have mostly independent etiologies and correlates (e.g.,
Watson et al., 1995).

Author Manuscript

There has been no systematic research, however, on the temporal course of tripartite model
dimensions. Therefore, it remains to be seen whether these components of anxiety and
depression change at the same rate, or in the same direction, over adolescence and young
adulthood. It is possible that the three dimensions represent distinct routes to emotional
disorder that follow divergent naturalistic courses. On the other hand, they may converge
over time to form one common pathway to disorder.

Author Manuscript

Although the tripartite model was not originally formulated as a developmental theory, some
hypotheses regarding temporal dynamics can be derived. Negative affect is posited as a
common thread across emotional disorder symptoms that correlates more highly with the
other two tripartite model dimensions than they do with each other, and change in negative
affect might therefore be expected to correlate with change in anhedonia and anxious arousal
over time. In contrast, anhedonia and anxious arousal are thought to reflect largely
independent systems, based on unique neurobiological and psychological underpinnings
(e.g., Forbes & Dahl, 2005; Forbes et al., 2009; Klein, Kotov, & Bufferd, 2011; Kotov,
Watson, Robles, & Schmidt, 2007). In cross-sectional analyses, these symptom domains
exhibit appropriate levels of discriminant validity (Brown et al., 1998; Watson et al., 1995).
Therefore, it could be argued that the developmental trajectories of these dimensions should
be largely unrelated.

Author Manuscript

Prior longitudinal research offers little empirical guidance for predictions about correlations
among developmental trajectories of the core dimensions of anxiety and depression. In one
early adolescent sample, latent curve modeling analyses revealed no significant correlation
between change in depressive symptoms and change in generalized, physical, separation, or
social anxiety symptoms (McLaughlin & King, 2015). In contrast, in a large sample of
Dutch adolescents, the corresponding estimates (r range: .32-.71) were moderate-to-large
over five years of follow up (Hale, Raaijmakers, Muris, van Hoof, & Meeus, 2009). Two
other longitudinal studies also reported substantial correlations (rs ≈ .60) in growth of
anxiety and depression (Leadbeater et al., 2012; Olino et al., 2014). However, it is important
to bear in mind that these estimates may be inflated to some extent by negative affect
pervading the assessment of anxiety and depressive constructs.
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In the present study, we charted the growth of basic psychopathological dimensions
undergirding anxiety and depressive disorders during adolescence and emerging adulthood.
We examined negative affect, anhedonia, and anxious arousal over five annual assessment
waves in a high risk sample of high school juniors. We had three research questions. First,
what are the direction and rate of symptom change? Second, how much variation exists
around the average symptom trajectory, and do the trajectories from different symptom
domains covary? Third, do symptom trajectories, and the degree of covariation among those
trajectories, differ by gender and comorbidity status?

Author Manuscript

Two opposing theoretical perspectives led to competing hypotheses regarding the trajectory
of mean-level symptom change (Question 1). On one hand, drawing from data on change in
personality trait levels over the life course, the maturity principle (Caspi, Roberts, & Shiner,
2005) holds that people tend to become more emotionally stable at the transition to
adulthood. That is, negative affect is theorized to wane as people make normative
commitments to conventional social roles, such as long-term romantic relationships, lifelong
friendships, occupations, and families (e.g., Robins, Caspi, & Moffitt, 2002; Robins, Fraley,
Roberts, & Trzesniewski, 2001). Perhaps because entry into many of these stabilizing social
institutions occurs in emerging adulthood, the transition to young adulthood is the period of
greatest change (i.e., reduction) in trait negative affectivity (see Roberts, Walton, &
Viechtbauer, 2006, for a meta-analysis). Therefore, it could be hypothesized that those
emotional disorder symptom dimensions most saturated with trait negative affectivity—in
the present study, negative affect and anxious arousal (see Mineka et al., 1998)—should
show reductions over the present study’s timeframe, which spans the transition from
adolescence to young adulthood.

Author Manuscript
Author Manuscript

On the other hand, the major social transitions accompanying emerging adulthood may
trigger anxiety and depressive symptoms among vulnerable people. The list of
developmental challenges at the transition to adulthood is long: for instance, leaving home,
beginning and ending romantic relationships, succeeding in academics, and choosing a
career (e.g., Helson, Kwan, John, & Jones, 2002). For that reason, Arnett (2000) referred to
emerging adulthood as “demographically dense.” Real, perceived, or anticipated failure to
successfully negotiate any of these age-graded social roles theoretically could provoke
anxiety and depression, especially among those prone to negative affect. As explained
below, our participants were over-sampled for adolescents endorsing high levels of trait
negative affectivity. Thus, consistent with a diathesis-stress viewpoint (e.g., Beck, 1979), it
could be argued that the transition to adulthood—with the demands of achieving normative
life tasks more salient than ever—should activate negative affect, anxious arousal, and
anhedonic symptoms in the present sample (cf. Rohde, Lewinsohn, Klein, Seeley, & Gau,
2013).
We expected to find significant variability in both the initial level and the amount of change
across all dimensions (Question 2). Further, based on prior theorizing—albeit mostly in the
context of cross-sectional symptom associations—about the structure of anxiety and
depression (e.g., Clark & Watson, 1991), we hypothesized that growth in negative affect
would, to some extent, correlate with both anhedonia and anxious arousal. In contrast, in line
J Abnorm Psychol. Author manuscript; available in PMC 2018 February 01.
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with prior theory and empirical evidence emphasizing their discriminant validity (e.g.,
Mineka et al., 1998), growth in anhedonia and anxious arousal was predicted to be mostly
independent. As described earlier, these specific dimensions of the tripartite model are
hypothesized to represent symptom dimensions that are distinctive to different emotional
disorders.

Author Manuscript

We examined a pair of background variables theoretically linked to the nature of emotional
disorder (co)development during adolescence and the transition to adulthood (Question 3).
We examined gender differences in symptom trajectories in light of the diverging emotional
disorder prevalence rates during this developmental stage (e.g., Ge, Conger, & Elder 2001).
We generated competing predictions with respect to gender. On the one hand, women are
expected to show steeper symptom increases (or flatter declines) because of the higher risk
for anxiety and depression during this period. On the other hand, if gender differences in
adolescence are largely mediated by neuroticism (e.g., Eaton et al., 2011), one would expect
no differences in symptom trajectories across gender because both men and women in the
present study were over-sampled on the basis of elevated neuroticism (see Methods). We
also predicted that diagnostic history would influence symptom development. We
concentrated specifically on those who had a history of anxiety and depressive diagnoses.
We hypothesized that comorbidity would predict not only the shape of symptom trajectories
(i.e., steady or increasing symptom patterns), but also the extent to which symptoms
changed together over time. That is, we expected that comorbid cases, by virtue of
possessing vulnerabilities for both anxiety and depression, would evidence a stronger
coupling of change across symptom domains over follow up.

Method
Author Manuscript

Participants

Author Manuscript

Participants were part of the Youth Emotion Project (YEP), a longitudinal study of the
development of emotional disorders. High school juniors were recruited in three cohorts
from schools in suburban Los Angeles and suburban Chicago. Those students who provided
assent and parental consent (N = 1,976) were administered the Neuroticism scale of the
revised Eysenck Personality Questionnaire (EPQ-R-N; Eysenck & Eysenck, 1975). A
subsample of 1,269 students was invited to participate in the YEP on the basis of EPQ-R-N
responses, overselecting for those in the highest Neuroticism tertile. There were 627 students
who completed the baseline assessment. Females were the larger portion of this sample
(68.7%), owing to greater likelihood of completing the screening questionnaire (56%
female), scoring higher on the EPQ-R-N, and accepting the invitation to participate. At
baseline, participants were an average of 16.9 years old (SD = 0.37). Participants identified
as Caucasian (50.2%), Hispanic/Latino (13.8%), African American (13.4%), Asian/Pacific
Islander (4.7%), other race/ethnicity (5.3%), and multiracial (12.6%). Additional details
regarding screening and selection procedures are available elsewhere (Zinbarg et al., 2010).
Measures
Mood and Anxiety Symptom Questionnaire (MASQ; Watson et al., 1995)—The
90-item MASQ was constructed to assess the general and specific symptom domains of the
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tripartite model of anxiety and depression. The MASQ has three general dimensions that
feature symptoms common to multiple anxiety and depressive disorders. The 15-item
General Distress: Mixed Symptoms scale includes symptoms that appear in the criterion sets
for both anxiety and depressive conditions (e.g., irritability, concentration difficulty,
insomnia) and represents the tripartite model spectrum of negative affect that characterizes
all emotional disorders. The General Distress: Anxious Symptoms scale assesses anxious
mood and other symptoms that empirically do not differentiate among various anxiety
disorders. Analogously, the General Distress: Depressive Symptoms scale includes items
assessing depressed mood and other nonspecific symptoms of mood disorder. The General
Distress: Mixed Symptoms (hereafter Mixed Symptoms) scale was preferred to the other
two because it captures symptoms of emotional distress that are identified in modern
nosologies as being symptoms of both anxiety and depressive disorders (Watson et al.,
1995).

Author Manuscript

Two scales contain items selected to index specific symptom dimensions of either anxiety or
depression. Anxious Arousal features 17 items related to somatic tension and hyperarousal
(e.g., dizziness, shortness of breath, shaking hands) that reflect the anxious arousal
dimension of the tripartite model. In contrast, the 22-item Anhedonic Depression scale
assesses the anhedonia tripartite domain with items related to loss of interest and positive
affective states (e.g., enjoyment, happiness). On all scales, respondents indicated on a fivepoint scale to what extent they had experienced each symptom (1 = not at all, 5 = extremely)
“during the past week, including today.”

Author Manuscript
Author Manuscript

Prior research on the latent architecture of the MASQ Anhedonic Depression scale in this
and other samples (Kendall et al., 2016; Keogh & Reidy, 2000; Watson, Clark, Weber, &
Assenheimer, 1995) indicates that it is multidimensional. That is, during MASQ
development, some items (i.e., those tapping the low end of positive affect such as “Felt
really bored,” “Felt withdrawn from other people,” “Felt unattractive”) cohered with MASQ
items intended to assess negative affect (Watson et al., 1995). A recent investigation into the
latent structure of the MASQ Anhedonic Depression scale using bifactor analysis found
support for an overarching general factor uniting all 22 items, but also for separate group
factors for the 8 items tapping low positive affect (and likely contaminated with negative
affect variance) and the remaining 14 tapping the high end of positive affect (Kendall et al.,
2016). Kendall et al. recommended separating these item sets in future research. Thus, to
achieve maximum discrimination between anhedonia and the other two tripartite
dimensions, we omit the 8 items thought to be saturated with negative affect and include in
our Anhedonic Depression scale only those 14 items assessing high positive affect (e.g.,
“Felt really cheerful,” “Looked forward to things with enjoyment,” “Felt really good about
myself”). Following MASQ scoring conventions, these 14 items were reverse-scored such
that higher values represent greater anhedonia.
The MASQ has demonstrated excellent psychometric properties in cross-sectional research.
Scale reliability values are consistently .80 and above across student, community, and patient
samples (Watson et al., 1995). The pattern of scale correlations is in line with tripartite
model predictions, such that the three General Distress dimensions are highly
intercorrelated, the General Distress dimensions are moderately correlated with Anxious
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Arousal and Anhedonic Depression, and Anxious Arousal and Anhedonic Depression are
weakly correlated (Watson et al., 1995). Also supporting the discriminant validity of the
specific dimensions, Anxious Arousal is far more related than Anhedonic Depression to
conventional measures of anxiety, whereas Anhedonic Depression is more closely connected
than Anxious Arousal to measures of depression. In the present study, scale reliability
estimates at baseline were all above .88 (range: .88 to .93).

Author Manuscript

Structured Clinical Interview for DSM-IV, Non-Patient Edition (SCID-I/NP)—The
SCID-I/NP (First et al., 2002) assesses DSM-IV (American Psychiatric Association, 1994)
diagnoses. The SCID-I/NP was administered at baseline to assess lifetime history of
emotional disorders (i.e., current and past diagnoses) up to and including Time 1. Diagnoses
occurring after Time 1 were not examined in this study to preserve the temporal precedence
of diagnostic history relative to symptom trajectories. Each completed SCID-I/NP was
presented at a consensus meeting led by doctoral-level supervisors. To qualify for a
diagnosis, participants had to meet DSM-IV criteria and be assigned a clinical severity rating
(CSR; Di Nardo & Barlow, 1988) of four or greater for that diagnosis. CSRs are used to
quantify symptom severity and the amount of impairment and distress present, and they are
rated on a scale of 0–8, with a 0 indicating no notable symptoms, distress, or interference, 1–
3 indicating subclinical severity, and ratings of four and higher indicating clinical
significance. Inter-rater reliability for both CSRs (Pearson rs > .70) and DSM-IV diagnoses
(kappas > .65) were in the acceptable to good range (see Zinbarg et al., 2010, for more
detail). The diagnostic frequencies (and percentages) at baseline were 112 (18%) major
depressive disorder, 7 (1%) dysthymia, 6 (1%) panic disorder, 53 (9%) social phobia, 13
(2%) obsessive-compulsive disorder, 4 (1%) posttraumatic stress disorder, 13 (2%)
generalized anxiety disorder, and 33 (5%) specific phobia. There were 48 comorbid cases
(8% of sample) at baseline with a history of both an anxiety and depressive disorder.

Author Manuscript

Procedures

Author Manuscript

Participants were recontacted 10 months after baseline, and each subsequent wave, to
complete the study assessment battery. Each successive assessment was administered
between 10 and 18 months after the prior assessment, and the mean interval between follow
ups was 0.94 year (SD = 0.12). If a participant was not reachable or available to complete a
given assessment (time t) in the 18 months following the previous wave (time t-1), he or she
was still contacted to participate in the following wave (time t+1). The available sample
sizes for the MASQ at baseline and the four follow up points were 604, 443, 326, 340, and
360. We compared 69 baseline respondents who did not participate at any subsequent wave
with those who did, and we found that attritors did not differ from other participants on any
baseline demographic or psychopathology index, that they reported higher levels of baseline
Anxious Arousal, t(601) = 2.00, p < .05. In addition, baseline variables generally were not
related to missingness at any single wave. The exceptions were that elevated Anxious
Arousal predicted missingness at Time 4, t(601) = 2.54, p < .05, and Time 5, t(601) = 2.93, p
< .05, and elevated Mixed Symptoms predicted missingness at Time 5, t(601) = 2.93, p < .
05.
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The MASQ was completed through a secure website at each assessment wave, and
participants were mailed a check upon completion. The Institutional Review Boards at
Northwestern University and UCLA approved all study procedures.
Statistical Analysis

Author Manuscript

We specified latent curve models (LCMs) to understand how each symptom domain changed
over time and the extent to which they changed in concert. LCM is well suited for those
research objectives because it assumes, unlike other statistical frameworks for studying
multivariate change (e.g., autoregressive cross-lagged models), an underlying growth
process that shapes the trajectory of observed repeated measures (Bollen & Curran, 2006;
Duncan & Duncan, 2004). Figure 1 presents a path diagram of a bivariate LCM that assumes
linear change in both constructs—here we use Mixed Symptoms and Anxious Arousal as
examples—over time. However, the multivariate LCM can easily be extended to include
additional constructs and alternate functional forms of change (e.g., polynomial models); our
example focuses on the linear bivariate case for simplicity. In the diagram, the LCM slope
factor means are represented by the regression of each factor on a constant value of unity
(shown in the triangle). The weights of these regressions (labeled α2 and α4) reflect the
direction (i.e., sign of the coefficient) and rate (i.e., magnitude of the coefficient) of
symptom change. Meanwhile, the random portion of each factor is represented by a separate
latent variable influencing the growth factors. Thus, the slope factor variances (ψ22 and ψ44)
reflect the degree of between-person variability in symptom trajectories, whereas the slope
factor covariance (ψ42) indexes the extent to which the two symptom trajectories are
correlated over time.

Author Manuscript

The first step in our analysis was to find the optimal functional form of change over time for
each symptom domain independently. In univariate models, we evaluated a linear growth
model in which slope factor loadings were specified as 0 (Time 1 [T1]), 1 (T2), 2 (T3), 3
(T4), and 4 (T5), and all intercept loadings were fixed at 1. We compared that linear model,
which assumes a constant rate of symptom change over follow up, with a quadratic model
that allows for a nonlinear trajectory (i.e., acceleration or deceleration in growth). In
quadratic models, we reparamaterized the factor loadings such that time was centered on T3
(i.e., linear trend factor loadings: −2, 1, 0, 1, 2) to avoid estimation problems related to linear
dependence among the linear and quadratic factors (Stoolmiller, 1995). A likelihood ratio
test (LRT) of nested models was used to judge whether the addition of quadratic effects
significantly improved model fit.

Author Manuscript

After we characterized the form of symptom growth in univariate analyses, we examined
correlations among symptom trajectories. In a trivariate LCM, we examined the crossconstruct covariances between the intercepts and rates of change for each pair of symptom
dimensions. In this trivariate model, cross-construct within-time error covariances (e.g., the
covariance between the Time 3 Mixed Symptoms error term and Time 3 Anxious Arousal
error term) were freely estimated. A LRT indicated that allowing these error covariances
significantly improved fit relative to a model in which they were fixed to zero, χ2Δ(3) =
389.46, p < .001. Further, these error covariances were constrained to equality over time for
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model parsimony; another LRT showed that these constraints did not significantly degrade
model fit for any of the three pairs of symptom dimensions, χ2Δ(4) < 7.50, ps > .10.

Author Manuscript

After determining the best fitting trivariate LCM, we compared it to the latent curve model
with structured residuals (LCM-SR; Curran, Howard, Bainter, Lane, & McGinley, 2014), an
alternate—and closely related—model of multivariate change. The LCM-SR is a hybrid of
LCM and autoregressive cross-lagged models that specifies autoregressive and cross-lagged
paths among adjacent residuals of the manifest variables, as opposed to the manifest
variables themselves. Thus, the LCM-SR is an extension of the LCM that includes includes
autoregressive and cross-lagged regressions of residual terms of repeated measures at time t
on residual terms of repeated measures at time t-1 (regressions onto more distal repeated
measure residuals [e.g., t-2] are possible but not tested here). These additional parameters
represent the degree to which departures from one’s expected trajectory at time t in one
construct predict deflections from one’s expected trajectory at time t+1 in the other
construct.

Author Manuscript
Author Manuscript

After empirically comparing the LCM and LCM-SR (and retaining the LCM), we examined
individual differences in symptom change as a function of gender and comorbidity. This
testing was performed in a multiple-groups structural equation modeling context, which
allows model parameters to vary across population subgroups. We chose the multiple-group
approach instead of specifying the covariates as exogenous predictors of growth factors
because the latter procedure only permits an examination of covariate effects on factor
means (see Bollen & Curran, 2006), whereas our primary interest was in how gender and
comorbidity influenced growth factor covariances (i.e., correlation of growth trajectories
across symptom dimensions). Testing followed a two-step process. First, in univariate
LCMs, we compared models in which factor means were constrained to equality across the
subgroups or varied freely. The LRT of the fit of these nested models indicated whether the
shape of change in each symptom dimension was constant across subgroups. Second, in a
series of bivariate LCMs, we compared models in which the factor variances and
covariances were equated versus freely estimated across subgroups. A significant LRT in
this step would indicate that the sample variance in the rate of change or the correlation in
change across symptom domains differed across subgroups. If an LRT was significant in
either step, we inspected the model modification indices (MIs) to determine which, if any, of
the model constraints led to poor fit. It should be noted that such post hoc inspection of MIs
can lead to model overfitting, or picking up on chance variation in a given sample, and we
therefore proceed with caution when interpreting MIs (e.g., MacCallum, 2001). Due to the
increasing number of significance tests, we followed an analog of the protected t-test
procedure whereby we only proceeded to examine the MIs for means and (co)variances if
the omnibus LRT was significant (Cohen, Cohen, West, & Aiken, 2003).
We assessed model fit with the comparative fit index (CFI), Tucker-Lewis index (TLI), root
mean square error of approximation (RMSEA), and standardized root mean square residual
(SRMR). We compared sample estimates of these criteria to guidelines for acceptable fit
offered by Hu and Bentler (1999). We also judged model fit on the basis of localized areas of
strain and the size and interpretability of parameter estimates. We used the robust maximum
likelihood estimator in Mplus (version 7.3, Muthén & Muthén, 1998–2014) for all analyses
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to account for non-normality in MASQ scale distributions, and missing data due to attrition
were accommodated using full information maximum likelihood estimation procedures (see
Allison, 2003).

Results
Descriptive Statistics

Author Manuscript

Table 1 presents the means and standard deviations of each symptom domain across time.
Average symptom levels were comparable to undergraduate norms reported in studies of
MASQ psychometrics (Watson et al., 1995). Also, Mixed Symptoms and Anxious Arousal
appeared to decline over time, whereas there was a small overall increase in Anhedonic
Depression. The corresponding effect sizes representing change between the symptom mean
at T1 to the symptom mean at T5, expressed in Cohen’s d (using standard deviations at T1),
were −0.47, −0.41, and 0.06 for Mixed Symptoms, Anxious Arousal, and Anhedonic
Depression, respectively.
Measurement Invariance

Author Manuscript

Measurement invariance was examined prior to fitting LCMs to verify that any observed
symptom change over time was true change in the underlying construct rather than
variability across time in the measurement properties of MASQ items (see Horn & McArdle,
1992). To evaluate measurement invariance, we estimated a series of confirmatory factor
analyses (CFAs) for each symptom dimension involving the two most distant waves (i.e., T1
and T5). That is, we compared CFAs with cross-time equality constraints on factor loadings
and indicator intercepts with models in which those parameters were allowed to vary freely.
In this analysis, each scale item was treated as a separate indicator of a latent variable
representing the relevant symptom dimension (e.g., each of the 17 Anxious Arousal items
was treated as an indicator of an Anxious Arousal factor). For each scale we tested for weak
(i.e., loadings but not intercepts) and strong (i.e., loadings and intercepts) measurement
invariance.

Author Manuscript

The results supported partial invariance for all three scales. According to LRTs and
comparison of other model fit indices (e.g., CFI, RMSEA), 1 factor loading was allowed to
vary across time for Anhedonic Depression, whereas all factor loadings were time-invariant
for Mixed Symptoms and Anxious Arousal. Regarding the intercepts, 4 (out of 15) on the
Mixed Symptoms scale, 6 (out of 14) on the Anhedonic Depression scale, and 2 (out of 17)
on the Anxious Arousal scale were non-invariant over time. Thus, we concluded that partial
invariance obtained and we could proceed with the LCM. (Full results are available upon
request from the first author.)
Unconditional Univariate Latent Curve Models
This series of LCMs aimed to quantify the rate and variability of symptom growth over time.
The observed patterns of change are depicted in Figure 2. We first compared linear and
quadratic models to evaluate the constancy of change in each symptom domain. Linear
models provided adequate fit for Mixed Symptoms, χ2(14) = 25.52, p < .05; CFI = .97; TLI
= 0.98; RMSEA = 0.04; SRMR = .06; Anxious Arousal, χ2(14) = 40.40, p < .001; CFI = .
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89; TLI = 0.92; RMSEA = 0.08; SRMR = .13; and Anhedonic Depression, χ2(14) = 29.44,
p < .01; CFI = .96; TLI = 0.97; RMSEA = 0.04; SRMR = .06. However, chi-square
difference tests indicated that the addition of a quadratic factor—including the factor mean,
variance, and covariances among the intercept and linear trend factors—significantly
improved model fit for each dimension: Mixed Symptoms, χ2Δ(4) = 56.11, p < .001;
Anxious Arousal, χ2Δ(4) = 64.72, p < .001; Anhedonia, χ2Δ(4) = 47.72, p < .001 (see Table
2 for quadratic model fit statistics).

Author Manuscript

Table 2 shows the parameter estimates—including factor means, variances, and correlations
—from the quadratic LCMs. As expected, the means of all intercept factors differed from
zero. More significantly, the large intercept variance estimates indicated wide cross-sectional
variation on each symptom dimension. The linear trend estimates1 for Mixed Symptoms and
Anxious Arousal were negative—indicative of a downward trajectory—and statistically
significant. There was also significant variability around the linear trend estimates,
suggesting that not all participants exhibited an equally precipitous drop in symptoms over
follow up.
Moreover, a statistically significant quadratic factor mean was observed for Mixed
Symptoms. The positive sign of the coefficient indicated that the decline in Mixed
Symptoms decelerated over the course of follow up, such that, on average, the linear trend
became approximately 0.56 units2 more positive at successive intervals. The quadratic trend
for Anxious Arousal was positive but not statistically significant. However, there was
significant variability around that estimate, indicating a wide degree of variation in the
expected curvature in Anxious Arousal symptom change over time.

Author Manuscript

The Anhedonic Depression trajectory diverged from that of Mixed Symptoms and Anxious
Arousal. The average linear trend over follow up was positive, although it only approached
conventional levels of statistical significance. The mean quadratic trend was positive but not
statistically significant. Further, significant variability in the quadratic factor revealed that
the amount of change in change over time varied across participants.
Unconditional Trivariate Latent Curve Model
The next analysis allowed us to examine covariances in properties of symptom change. The
correlations among intercept factors—representing symptom levels at Time 3, since time
was centered at the middle assessment wave—provided insight into cross-sectional
associations between symptom domains. Mixed Symptoms had a strong association with
Anxious Arousal (r = .73). In contrast, the intercept correlations of Anhedonic Depression
with Mixed Symptoms (r = .36) and Anxious Arousal (r = .20) were small-to-moderate.3

Author Manuscript

1In the quadratic model, the (simple) linear trend estimates are interpreted as the slope of the tangent to the curve at the model
intercept (i.e., Time 3). The linear trend estimates from the quadratic LCMs were virtually identical to the slope factor mean estimates
from linear LCMs (results available upon request).
2The rate of change in the linear trend per unit time is double the quadratic factor mean (e.g., for Mixed Symptoms: 2 × 0.28).
3In an exploratory analysis, we respecified the intercept location at the other assessment waves to figure out whether cross-sectional
associations between the symptom domains changed over the course of the study. We did not detect any systematic trends in the size
or pattern of intercept intercorrelations across waves. The range of intercept correlations for Mixed Symptoms and Anxious Arousal
was .71-.78; that of Mixed Symptoms and Anhedonic Depression was .24-.36; and that of Anxious Arousal and Anhedonic
Depression was .09-.20.
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Table 3 presents zero-order correlations between growth factors. We focus on the crossconstruct correlations between linear and quadratic factors to understand the degree of
correspondence in change over time among tripartite model dimensions. The linear change
in Mixed Symptoms was significantly and positively related to that in Anxious Arousal (r = .
59). In contrast, the correlation in linear change between Mixed Symptoms and Anhedonic
Depression (r = .27) did not reach statistical significance, and that between Anhedonic
Depression and Anxious Arousal (r = -.02) was non-significant and almost nil. Constraining
the covariances among linear factors to equality produced a significant decrement in model
fit, χ2Δ(2) > 11.30, p < .01, indicating that these correlations differ significantly in
magnitude. An analogous pattern of correlations emerged for the quadratic factors. The
Mixed Symptoms quadratic trend (i.e., the upward bend in trajectory over follow up) was
strongly related to that of Anxious Arousal (r = .75) but not Anhedonic Depression (r = .35).
There was a small association between quadratic trends in Anhedonic Depression and
Anxious Arousal (r = .15).4 As with the linear factors, fixing all three quadratic factor
covariances to equality significantly worsened model fit, χ2Δ(2) > 6.47, p < .05, again
suggesting that tripartite quadratic trajectories are not all related equally.
Alternate Model for Multivariate Change

Author Manuscript

As described above, we aimed to compare the fit of the LCM to the LCM-SR to determine
whether any prospective relations among the symptom constructs were evident after
accounting for the latent growth processes thought to shape tripartite symptom trajectories.
We began by specifying a trivariate LCM-SR to correspond to our final trivariate LCM. As
in the LCM, we specified a quadratic functional form for all three constructs. The trivariate
LCM-SR produced an improper solution; the estimates for the variances of the linear and
quadratic trends for all symptom constructs were negative. (We also observed a negative
variance estimate for the linear trend in sensitivity analyses that omitted the quadratic
factor.) In ad hoc analyses we constrained the variances of the linear and quadratic factors to
zero. These constraints led to a reasonable model fit, χ2(93) = 81.95, p = .80; CFI = 1.00;
TLI = 1.00; RMSEA = 0.00; SRMR = .05; however, none of the cross-lagged paths were
significantly different from zero (all standardized cross-lags were smaller than |.04|). In other
words, they did not explain the longitudinal correlation among symptom domains above and
beyond the latent growth trajectories. We interpreted this set of results as indicating that
cross-lagged paths across symptom constructs do not add meaningfully to our understanding
of the nature of symptom co-development in this sample. Thus, we rely on the multivariate
LCM for interpretations of the direction, size, and covariance of symptom trajectories, and
we carry it forward to examine predictors of individual differences in those trajectories.

Author Manuscript

4We mentioned above that our main analyses omitted the 8 Anhedonic Depression items previously found to be saturated with
negative affect variance and meaningfully distinguished in bifactor analyses from the 14 Anhedonic Depression items tapping the high
end of positive affect (Kendall et al., 2015; Watson et al., 1995). Here we present the pattern of growth for a dimension comprised of
those 8 Anhedonic Depression items that appear to assess the low end of positive affect. Linear growth for this dimension was negative
(b = −0.82, p < .001) with significant interindividual variability around that estimate. The quadratic factor mean was not significantly
different from zero. In parallel process growth models, the Anhedonic Depression intercept was very closely related to the intercepts
for Mixed Symptoms (r = .93) and Anxious Arousal (r = .70). Moreover, the correlation in Anhedonic Depression’s linear trend with
Mixed Symptoms (r = .77) was remarkably high; it had a more moderate longitudinal association with Anxious Arousal (r = .33).
Paralleling the pattern of linear trend associations, the correlations among quadratic factors were .90 for Mixed Symptoms and .64 for
Anxious Arousal. Overall, these results supported the notion that a subset of MASQ Anhedonic Depression items may reflect negative
affect and therefore might not be optimal indicators of the anhedonia dimension (for details, see Kendall et al., 2015).
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When growth factor means were constrained to equality across gender, model fit worsened
only in the Anhedonic Depression model, χ2Δ(2) = 10.79, p < .01. Inspection of the MIs
revealed that only the model intercept differed across gender, χ2(1) = 8.17, p < .01.
Specifically, men (M = 44.66) had higher Anhedonic Depression levels at the study midpoint than women (M = 41.80). No factor variances or cross-construct covariances varied as
a function of gender.

Author Manuscript

Factor means were found to differ across comorbidity status for all three symptom
constructs, χ2Δ(3) > 10.30, ps < .01. For Mixed Symptoms, MIs indicated that the intercept
factor mean was higher for comorbid cases (comorbid group: M = 33.16; non-comorbid
group: M = 28.44), χ2(1) = 18.80, p < .001. Further, the quadratic factor mean was larger for
comorbid cases (comorbid group: M = 1.15, SE = 0.45, p < .05; non-comorbid group: M =
0.20, SE = 0.11, p = .06), χ2(1) = 15.49, p < .001. For Anhedonic Depression, the intercept
factor mean was also higher for comorbid cases (comorbid group: M = 46.56, SE = 1.53, p
< .001; non-comorbid group: M = 42.34, SE = 0.50, p < .001), χ2(1) = 9.31, p < .01. For
Anxious Arousal, only the quadratic factor mean differed across groups (comorbid group: M
= 0.86, SE = 0.25, p < .001; non-comorbid group: M = 0.06, SE = 0.10, p = .56), χ2(1) =
15.73, p < .001.5 Factor variances and cross-construct covariances did not vary significantly
by comorbidity status.

Discussion

Author Manuscript

We mapped the trajectory of core dimensions of emotional disorders across five annual
assessment waves beginning in adolescence. We observed reductions over follow up in
negative affect and anxious arousal symptom levels, but no significant change in anhedonia.
We also found that the rate of change in these symptoms appeared to change over time; that
is, emotional disorder development during this period was not entirely linear. Just as
important, we demonstrated that the rate of symptom change—and changes in the rate of
change—are not necessarily correlated across tripartite domains. Specifically, anhedonia
progressed fairly independently from negative affect and anxious arousal.

Author Manuscript

The patterns of change in tripartite domains suggest that emotional disorder symptoms do
not uniformly rise or fall during emerging adulthood. Consistent with the maturity principle
(Caspi et al., 2005), which posits that accomplishment of normative life tasks (e.g., choosing
a career, beginning serious romantic relationships) at the transition to adulthood should be
accompanied by reductions in trait negative affectivity, we found declining trajectories for
negative affect and anxious arousal (cf. Robins et al., 2001). In contrast, adolescents did not
“mature out” of anhedonic symptoms at the transition to adulthood. If anything, these
symptoms appeared to worsen somewhat over this period. This observation accords with
findings from community studies that document substantial continuity of depressive

5Supplementing our analyses of comorbidity effects on growth factor means, we regressed these factor means on a trichotomous
independent variable reflecting EPQ-R Neuroticism tertiles (see Methods), a proxy for baseline emotional disorder risk (similar to a
history of diagnostic comorbidity). In line with previous studies in community and patient samples (e.g., Brown & Rosellini, 2011;
Galambos et al., 2006), we found that higher Neuroticism levels were associated with significantly greater baseline levels and steeper
linear declines across all three symptom dimensions, consistent with regression to the mean (full results available upon request).
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symptoms and disorders from adolescence to emerging adulthood, including peak rates of
depressive disorder recurrence (e.g., Rohde et al., 2013). Moreover, the persistence of
anhedonia is in line with the theory that the “demographically dense” transition to adulthood
—featuring novel social challenges such as leaving home and navigating long-term romantic
relationships—set the stage for depression among vulnerable people (see Arnett, 2000).
However, such changes in anhedonia might also be consistent with a wide range of other
developmental processes (e.g., normative development of reward processing systems, less
time for engagement in pleasurable activities). Additional research is needed to determine to
what extent developmental challenges at the transition to adulthood shape the naturalistic
course of emotional disorder features.

Author Manuscript

Our findings extend prior developmental studies by distinguishing between general and
differentiating features of emotional disorders. That is, previous work typically has involved
assessments that conflate the core dimensions of anxiety and depression (cf. Clark &
Watson, 1991). Therefore, the naturalistic course of the specific and distinctive variance in
observed scores on depressive symptom measures have been associated with fluctuations in
anxiety to an unknown extent (and vice versa). By modeling the tripartite dimensions over
time, we charted separate courses for negative affect, which characterizes all emotional
disorders, and more specific components of anxiety and depression. This distinction proved
revealing, as negative affect declined monotonically over late adolescence, whereas
anhedonia—a specific dimension to unipolar depression and social phobia—exhibited
comparatively little growth (in the opposite direction). This result aligns with previous
treatment research that shows anhedonia is the emotional disorder dimension least likely to
change with intervention (Craske et al., in press).

Author Manuscript

Just as important as the symptom trajectories were the correlations among those trajectories.
We showed, for the first time, that negative affect, anhedonia, and anxious arousal symptoms
do not travel together as a “lump” across development. The correspondence between linear
change in anhedonia and negative affect was nearly half (standardized coefficient ~= .30)
that of anxious arousal and positive affect (~ .60). The standardized relation between
anhedonia and anxious arousal linear factors was virtually nil. Although this pattern of
correlations does not rule out meaningful associations between aspects of change in
anhedonia with other tripartite dimensions, it did appear that anhedonia development was
more weakly related to negative affect and anxious arousal than those two constructs were
with one another. This finding is consistent with our knowledge of the cross-sectional
architecture of emotional disorders (e.g., Mineka et al., 1998), and they support the notion
that anxious arousal and anhedonia represent independent pathways to emotional disorders.

Author Manuscript

The nature of symptom growth—including relations among symptom trajectories—did not
differ significantly for men and women. This result might be attributable to our sampling
procedure, which overselected men at risk for emotional disorders. In other words, our data
suggest that, if risk status is held constant, gender differences in the time course of symptom
development in late adolescence are small. Alternatively, this pattern may be specific to the
developmental stage under study (i.e., the transition from adolescence to adulthood). In early
adolescence, gender differences in the rate of depression change, and perhaps the correlation
between the rate of depression and anxiety symptom change, should be more apparent
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according to established theory and longitudinal data (e.g., Ge et al., 1994; Lubke et al.,
2015). More generally, we might expect symptom trajectories to respond to emotion-relevant
biological (e.g., hormonal) and social (e.g., peer relations) processes as they come online,
which can occur at different ages, and in qualitatively different fashion, for men and women
(see, e.g., Hankin & Abramson, 2001).

Author Manuscript

Unlike gender, comorbidity appeared to have a systematic influence on the developmental
map of tripartite symptoms. We found a pattern of elevated intercept levels among comorbid
cases, as might be expected given the positive association between comorbidity and overall
severity of emotional disorders (e.g., Brown, Campbell, Lehman, Grisham, & Mancill,
2001). We also found that when symptoms tended to decline over follow up—as was the
case for negative affect and anxious arousal—the typical path of improvement was slowed
over time in the comorbid group. That is, the normative trajectory of symptom reductions
was not as steep—as reflected in larger quadratic factor means—among comorbid cases.
However, counter to predictions, there was no evidence of differences in cross-construct
covariances of symptom trajectories by comorbidity status. This result implies that the
developmental trajectories of anxiety- and depression-specific symptoms are no more
closely correlated for comorbid cases than for others. Stated differently, the unique
components of anxiety and depression grow independently over time even among those who
possess vulnerabilities for both anxiety and depression.

Author Manuscript
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Several study limitations point to directions for future research. First, as observed earlier, the
present sample was overselected for elevated trait negative affectivity, and results may not be
characteristic of the general adolescent population. Although the average symptom levels in
our sample were no higher than those reported in normative undergraduate samples (Watson
et al., 1995), it is possible that regression to the mean may have biased our trajectory
estimates, at least for high risk subgroups. We note, however, that a recent simulation study
suggests that this type of oversampling does not seem to bias appreciably effect size
estimates in behavioral research (Hauner, Zinbarg, & Revelle, 2014). Second, our analysis
spans a critical period of emotional disorder development, but our results cannot be assumed
to apply to other developmental epochs. Theory suggests that trait negative affectivity should
continue to decline as young adults age (e.g., Caspi et al., 2005), but very few longitudinal
data on the progression of relevant emotional disorder symptoms are available. Analogously,
fluctuations in anhedonia may be most pronounced in early adolescence, when the incidence
of depressive disorders climbs markedly. In fact, disrupted reward processing is evident even
in disorder-free children who are at risk for depression (Gotlib et al., 2010). Thus, future
research is needed to discover the time course of anhedonic (and other) symptoms in early
developmental epochs. Third, the MASQ has undergone psychometric development since
the start of the Youth Emotion Project. Its successor, the Inventory of Depression and
Anxiety Symptoms (IDAS; Watson et al., 2007), includes symptom dimensions that provide
coverage of additional specific features thought to differentiate anxiety and depression (e.g.,
lassitude, traumatic intrusions). Future empirical work with the IDAS and other multifaceted
transdiagnostic models such as the trilevel model (e.g., Naragon-Gainey, Prenoveau, Brown
& Zinbarg, in press; Prenoveau et al., 2010) will shed more light on change in emotional
disorder risk across development. Fourth, in some research contexts it can be theoretically
and empirically challenging to differentiate symptom dimensions from related temperament
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and personality processes (e.g., Krueger & Tackett, 2003). Our focus here was on change in
emotional disorder symptoms, but it remains unclear to what extent the personality
dimensions underlying anxiety and depression follow the same pattern of development.
Future work is needed to directly compare, and examine causal influences between,
symptom versus personality development over time (e.g., Clark, 2005; Morey & Hopwood,
2013). Fifth, 11% of the baseline sample did not participate in any follow up wave, and
attritors endorsed higher levels of baseline anxious arousal symptoms. Although we used
full information maximum likelihood, which is preferred to other methods for handling
missing data (e.g., listwise deletion), differential attrition may still limit to some extent the
generalizability of the results. Finally, (multiple-indicator) latent variable repeated measures
can be incorporated into LCM to remove measurement error from growth factor indicators
(e.g., Preacher, Wichman, MacCallum, & Briggs, 2008). Here we used single indicator
repeated measures (i.e., MASQ scale means) to limit model complexity; however, it must be
acknowledged that the factor indicator variance included measurement error.
In sum, we charted the trajectories of core dimensions of emotional disorders from
adolescence into emerging adulthood. We found that the developmental trends for negative
affect, anhedonia, and anxious arousal can look very different—and occasionally proceed in
opposite directions—during this period. We also discovered that the rates of change in these
symptom domains are not always strongly (or even minimally) correlated. Together, these
results suggest that divergent pathways to emotional disorders are possible during this key
developmental stage.
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Figure 1.

Path diagram for the bivariate linear latent curve model for Mood and Anxiety Symptom
Questionnaire Mixed Symptoms and Anxious Arousal measured at five occasions. η1 and η3
represent intercept factors, whereas η2 and η4 represent linear trend factors. The ψs
represent factor variances and covariances, and the αs denote factor means. Following path
diagram conventions, rectangles represent observed variables and circles represent latent
variables. Growth factor means are represented by regressing the factors onto a constant
(unity). Within-time residual covariances are omitted for clarity of presentation.
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Figure 2.

Repeated measures of Mood and Anxiety Symptom Questionnaire scales. (A) General
Distress: Mixed Symptoms; (B) Anhedonic Depression; (C) Anxious Arousal.
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Unstandardized Parameter Estimates from Unconditional Univariate Latent Growth Models for Mixed
Symptoms, Anxious Arousal, and Anhedonic Depression
Parameter

Mixed
Symptomsa

Anxious
Arousalb

Anhedonic
Depressionc

Intercept variance

62.76 (7.54)***

47.09 (7.32)***

73.62 (7.65)***

Linear trend mean

−1.13 (0.13)***

−0.82 (0.10)***

0.28 (0.16)†

Linear trend variance

2.45 (0.64)***

2.05 (0.61)***

5.27 (0.93)***

−.15 (.12)

−.09 (.12)

.01 (.10)

Quadratic trend mean

0.28 (0.11)**

0.13 (0.10)

0.13 (0.12)

Quadratic trend variance

1.30 (0.46)**

1.66 (0.41)***

1.73 (0.57)**

Quadratic trend-intercept r

−.44 (.10)***

−.52 (.10)***

−.45 (.08)***

−.20 (.20)

−.50 (.20)*

.13 (.17)

Linear trend-intercept r

Author Manuscript

Quadratic trend-linear trend r

Note. N = 606. Standard errors appear in parentheses.
†

p < .10,

*

p < .05,

**
p < .01,
***
p < .001.
a

Model fit: χ2(10) = 9.04, p = .53; CFI = 1.00; TLI = 1.00; RMSEA = 0.00; SRMR = .03.

b

Model fit: χ2(10) = 9.77, p = .46; CFI = 1.00; TLI = 1.00; RMSEA = 0.00; SRMR = .05.

c

Model fit: χ2(10) = 16.05, p = .10; CFI = .98; TLI = 0.98; RMSEA = 0.03; SRMR = .06.
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−.44***

−.27*

−.30**

.09

−.23

MIXQ

AROL

AROQ

ANHL

ANHQ

−.13

.07

−.52***

−.09

−.34**

−.02

.20**

ARO

−.45***

.01

−.10

−.03

−.23*

−.02

ANH

.03

.27

−.25

.59***

−.19

MIXL

.35

−.14

.75***

−.23

MIXQ

−.09

−.02

−.50*

AROL

Trends

.15

−.08

AROQ

.13

ANHL

Note. N = 606. Model fit: χ2(75) = 73.50, p = .53; CFI = 1.00; TLI = 1.00; RMSEA = 0.00; SRMR = .04. MIX = Mixed Symptoms; ARO = Anxious Arousal; ANH = Anhedonic Depression; L subscript
denotes linear factor; Q subscript denotes quadratic factor.
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